Start with the sample, not the percentage
A peptide certificate of analysis, usually shortened to COA, is a document about a sample. That sounds obvious, but it is the distinction most easily lost when a certificate becomes a marketing badge. A report does not automatically describe every vial sold under the same product name. It does not establish the current contents of a warehouse. It does not tell you whether a person should use the substance. Before reading the largest number on the page, identify the object to which every number refers. Write down the product name, stated sequence or identifier, batch number, sample identifier, test date and report date. Keep those fields separate. A batch number identifies a production group; a laboratory sample number identifies the submitted material. They can be linked, but the connection should be explicit. If a seller shows several documents, compare these fields across all of them. A purity report and a sterility report with different sample identifiers should not silently become a single comprehensive certificate.
Find out who submitted the material
An independent laboratory can test a sample selected and submitted by the supplier. That is useful, but it answers a different question from testing a sample purchased without the supplier knowing which item would be selected. The laboratory's independence concerns who performed the measurement. Sampling independence concerns how the material reached the laboratory. A good review describes both rather than compressing them into a single third-party badge. Ask whether the sample was supplied by the manufacturer, selected by a retailer, purchased by a customer or obtained through a documented independent sampling programme. Then ask what evidence supports that account. A photograph, invoice or chain-of-custody record may improve traceability, but each has limitations. Do not infer that an attractive report layout proves a blind purchase. Equally, do not dismiss a supplier-submitted test as worthless. Its value is real but narrower than an independently sampled market survey.
Separate identity from purity
Identity asks whether the target substance is the expected molecule. Purity asks how much of the measured analytical signal is assigned to that substance under a particular method. Those questions overlap in practice but are not interchangeable. A report should make clear which method supports identity and which supports the purity result. HPLC and mass spectrometry are commonly discussed together because their information can complement one another. Suppose a hypothetical certificate says only “purity: 99%” without naming the analyte or method. That statement leaves substantial ambiguity. Now imagine a report that specifies a peptide identifier, an expected molecular mass, an observed mass and a chromatographic method. The second document gives the reviewer more to inspect, even before considering whether its results are favourable. Documentation quality begins with making a claim precise enough to challenge. Precision does not guarantee correctness, but vagueness makes meaningful verification much harder.
Understand the denominator
A percentage is a fraction with a denominator. When people discuss a peptide's HPLC purity, the denominator may concern integrated chromatographic peak area under the reported conditions. It is not necessarily the total mass inside the vial. Water, counterions, residual solvents or components not captured by that analytical method can make the relationship between a purity percentage and total material more complicated. Use a hypothetical example: a sample could have a strong main peptide peak while its total powder mass includes material that is not counted in that peak-area calculation. Multiplying the vial's nominal powder weight by the purity percentage would then be an unsupported shortcut for calculating peptide content. The practical response is to request a separate quantitative determination with units and method details. The question is not whether percentages are useful. It is whether the percentage answers the question you are asking.
Read quantity as its own result
A useful quantity result identifies the measured amount, the units and the basis of calculation. It might refer to material per vial, concentration in a prepared solution or net peptide content. Those are not the same quantity. A reviewer should be able to tell which one is reported and how it relates to the product label. If that connection is unclear, record the uncertainty rather than inventing a conversion. Imagine a nominal ten-milligram product with a measured result that differs from ten milligrams. Before describing it as underfilled or overfilled, examine the measurement uncertainty, sampling procedure and definition of the label claim. The result may still deserve attention, but the wording should fit the evidence. One unusual sample cannot establish an average for an entire supplier. A single favourable sample also cannot establish consistency. Quantity accuracy becomes a stronger finding when multiple independently selected lots are measured comparably over time.
Look for methods and reporting limits
A contaminant result needs more than the words pass or not detected. The relevant method, units, reporting limit and acceptance criterion should be identifiable. A method can report no detection while still being unable to rule out lower concentrations. That is not a defect unique to peptide testing; it is a normal feature of measurement. The mistake is turning a bounded result into a claim of absolute absence. A hypothetical “less than X” result should be read literally. It establishes an upper reporting statement under the method, not an exact zero. If the summary says one thing and the detailed table appears to say another, stop and request clarification. Do not resolve the inconsistency by choosing the more reassuring interpretation. Do not choose the more alarming interpretation either. A transparent review can state that the fields are inconsistent and withhold the relevant conclusion until the issuing laboratory explains them.
Keep sterility and endotoxins distinct
Sterility-related testing and endotoxin testing address different questions. They should appear as separate evidence fields with their own methods and sample references. A certificate that includes one does not automatically include the other. Similarly, a general microbial count is not simply another spelling of a sterility test. The report's actual terminology matters because different tests support different conclusions. The FDA's guidance on pyrogen and endotoxin testing is a useful primary reference for understanding the regulatory context. For a reader comparing public reports, the immediate task is more modest: identify exactly which panel was performed and avoid filling empty cells from assumptions. If endotoxin information is absent, mark it absent from the reviewed evidence. Do not mark the sample contaminated. If a seller describes a broad testing programme but provides only a purity certificate, separate the programme claim from the document you could inspect.
Authenticate through an independent route
A laboratory name printed on a PDF is an attribution. Authentication means checking that attribution through a channel controlled by the laboratory. A report-verification portal can help if the domain itself is authentic and the retrieved record matches the document. A QR code is a convenient link, not an independent guarantee. Check where it leads before trusting what it displays. If a report cannot be verified publicly, the appropriate next step may be direct confirmation from the laboratory. Record what was confirmed: document existence, report contents, sample identity or something else. These are different levels of assurance. A laboratory may confirm that it issued a report without being able to confirm what a retailer subsequently shipped. Keep the chain of reasoning intact. Authentication strengthens confidence in the report; it does not magically extend the report to untested material or answer clinical questions.
Review the whole chromatogram cautiously
A chromatogram can provide context that a single percentage hides, including the timing and appearance of separated signals. However, a screenshot without method details is not an invitation to diagnose every small feature by eye. Integration settings, detector response and separation conditions affect interpretation. A non-specialist should be especially careful about assigning chemical identities to peaks without supporting analysis. Useful questions include whether the full run is shown, whether the main peak is identified, whether the integration is documented and whether the report explains relevant impurities. A cropped image might simply be a poor presentation choice, or it might omit important information; the image alone cannot determine which. Request the complete report before escalating the claim. The strongest public review is often a carefully bounded description of what the document contains and what additional material would allow a more confident interpretation.
Make a one-page evidence record
You do not need an elaborate spreadsheet to improve your reading. Create a short record with the supplier, product, sample identifier, batch, date, laboratory, identity method, purity method, quantity result and contaminant panels. Add a separate column for what you actually inspected and another for what the supplier merely states. This prevents a general quality claim from quietly becoming a verified result when you revisit the information later. Finish with three sentences: what the report supports, what it does not support and what would resolve the most important uncertainty. For example, a historical sample report may support a statement about that sample's measured identity and content while leaving current inventory, additional contaminants and clinical suitability unanswered. That is a useful conclusion. A COA becomes valuable when it makes the evidence more specific, not when it removes every question. Keep the original source link and access date so another reader can check your interpretation.
Keep an audit trail when the report changes
A supplier may replace a document after a correction or publish a newer batch result. Record which version you read and when you accessed it. If a numerical field changes, distinguish a corrected report from a new sample rather than assuming they are interchangeable. The reason for a revision can matter as much as the revised number. Preserve enough context for another reviewer to follow the change, while respecting any private information in the document. A transparent correction improves the evidence record; silently combining old and new fields makes the record harder to reconstruct and can create conclusions that neither version actually supports.
Check the population, product, route, comparator and outcome. A laboratory mechanism is not a proven health benefit, and a supplier’s certificate is not a clinical study.
Follow the evidence
Sources accessed 10 September 2026. Vendor claims and vendor-hosted reports are identified as such.